GS Biotech completes USD14.04 million Pre-A financing

Summary: In Dec., GS Biotech completed a Pre-A round of financing generating around USD14.04 million (RMB100 million) for development of HMF, FDCA, THFDM business. On 5 Dec., 2022, Zhongke Guosheng (Hangzhou) Technology Co., Ltd. (GS Biotech) disclos...

Bio-based Material Quarterly Newsletter Q4 2022

www.cnchemicals.com